This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Antonella Antignani: Innovator in Monoclonal Antibodies
Introduction
Antonella Antignani is a prominent inventor based in Potomac, MD (US). She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her work has the potential to impact various medical applications, especially in cancer treatment.
Latest Patents
Antonella holds a patent titled "Monoclonal Antibodies That Bind EGFRVIII and Their Use." This patent represents her innovative approach to targeting specific proteins associated with cancer, showcasing her expertise in the field.
Career Highlights
Antonella is affiliated with the United States of America, as represented by the Secretary, Department of Health and Human Services. Her role in this esteemed organization highlights her commitment to advancing healthcare through scientific research and innovation.
Collaborations
Throughout her career, Antonella has collaborated with notable professionals, including Robert Joseph Sarnovsky and David J FitzGerald. These partnerships have further enriched her research and contributed to her success in the field.
Conclusion
Antonella Antignani's work in monoclonal antibodies exemplifies the impact of innovative research in biotechnology. Her contributions continue to pave the way for advancements in medical treatments and therapies.